Josef Walek

MBG Mittelständische Beteiligungs Baden-Württemberg GmbH (MBG Baden-Württemberg) is the private equity and venture capital division of Bürgschaftsbank Baden-Württemberg GmbH. The firm was founded in 1971. It is headquartered in Stuttgart, Germany.

IKB Invest GmbH (IKB-PE) is the private equity arm and a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). The bank's activities include domestic corporate lending, real estate finance, structured finance, private equity, treasury and financial markets. KfW holds a significant minority interest in the IKB group, and both banks have established a strategic partnership. Another significant shareholder is Stiftung Industrieforschung, a foundation established in 1974 following the merger between IKB-Industriekreditbank and Deutsche Industriebank, for the purpose of promoting commercial enterprise. Established in 1987, IKB-PE is headquartered in Dusseldorf, Germany.

IKB Equity Finance GmbH (IKB-EF) is a wholly-owned subsidiary of IKB Private Equity GmbH which is part of the private equity arm and in turn a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). IKB-EF was established in 2007 when the bank's private equity arm was reorganized. The firm focuses on direct equity investments while IKB Private Equity GmbH specializes in mezzanine financing.

CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany.